Sarepta (SRPT) calls active after FDA approves eteplirsen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/25/2026

1. NVDA
2. SPY
3. AAPL
4. XPEV
5. VEEV
6. DKS
7. BMO
8. MU
9. USO
10. NYAX

Go back to Sarepta (SRPT) calls active after FDA approves eteplirsen
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 18.84 +0.71 (3.92%)
Previous Close $18.13    52 Week High $63.73 
Open $18.42    52 Week Low $8.00 
Day High $19.05    P/E N/A 
Day Low $18.19    EPS $-5.69 
Volume 507,955